Lymphocytic Colitis: Clinical Trials

1 trial for Lymphocytic Colitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Lymphocytic Colitis: new trials by email Literature Review of Lymphocytic Colitis trials Research Report on Lymphocytic Colitis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis
Budesonide, Mesalamine, Placebo - Lymphocytic Colitis
Phase 3CompletedDr. Falk Pharma GmbH572010-05-012017-07-26

Narrower conditions

Colitis, Lymphocytic (1)

Broader conditions

Colitis (1)  ·  Colitis, Microscopic (1)  ·  Colonic Diseases (1)  ·  Digestive System Diseases (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Intestinal Diseases (1)

Interventions

Budesonide (1)  ·  Mesalamine (1)

Sponsors

Dr. Falk Pharma GmbH (1)

Countries

Germany (1)

Top investigators

Stephan Miehlke, Professor (1)

Results publications

PMID 30195447

NIH funding

2008 (1)